Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan.
Telmisartan is an orally active nonpeptide angiotensin II receptor antagonist used in the management of hypertension. It is a Biopharmaceutics Classification System class II drug having aqueous solubility of 9.9 μg/ml. Telmisartan (TEL) nanocrystals were prepared by evaporative antisolvent precipitation technique using different stabilizers as PVPK30, TPGS, Poloxamer 188, and PEG 6000 in combination or singly. The nanosuspensions were characterized in terms of particle size distribution, zeta potential, and polydispersity index. The suspension containing PVPK30 and TPGS (1:1) showed least average particle size of 82.63 nm and polydispersity index of 0.472. The zeta potential of nanosuspensions ranged between 6.54 and 10.8 mV. An increase of 116.45% was evident in the specific surface area of the freeze-dried product. Contact angle of nanoparticles was also lowered to 27° as compared to 50.8° for TEL. Saturation solubility studies in various media revealed a significant increase in comparison to plain drug. An increase of 3.74× in saturation solubility in FaSSIF and 5.02× in FeSSIF was seen. In vitro dissolution profile of nanosuspension coated on pellets revealed release of 85% in water, 95% in 0.1 N HCl, and 75% in phosphate buffer in 30 min. Nanosuspensions were found to be stable in the presence of univalent and bivalent electrolytes. A tenfold increase in bioavailability was evident. Nanoparticles of telmisartan prepared by bottom-up technique proved to be effective in improving the oral bioavailability as a result of enhanced solubility and dissolution rate.
Department of Pharmaceutics, SVKM'S B.N. College of Pharmacy, Mumbai, India. bajajamrita@gmail.com
Amrita
A
Bajaj
Monica R P
MR
Rao
Amol
A
Pardeshi
Dhanesh
D
Sali
D001562:Benzimidazoles / Q000737:chemistry* / Q000493:pharmacokinetics; D001565:Benzoates / Q000737:chemistry* / Q000493:pharmacokinetics; D001682:Biological Availability; D011232:Chemical Precipitation; D003460:Crystallization / Q000379:methods*; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry; D053758:Nanoparticles / Q000737:chemistry*; D036103:Nanotechnology / Q000379:methods*; D010316:Particle Size; D012995:Solubility; D013535:Suspensions / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000379:methods*; D000077333:Telmisartan
D001562:Benzimidazoles; D001565:Benzoates; D005079:Excipients; D013535:Suspensions; D000077333:Telmisartan